{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:55:56Z","timestamp":1763682956367,"version":"3.45.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Oncology Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.oor.2024.100488","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T05:41:22Z","timestamp":1714974082000},"page":"100488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Determinants of outcome in cancer patients with medication-related osteonecrosis of the jaw: A 19-year retrospective study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9766-8708","authenticated-orcid":false,"given":"Jenna","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-4492","authenticated-orcid":false,"given":"Annu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1671-3155","authenticated-orcid":false,"given":"Charlie","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyn","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanne","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SaeHee K.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2080-5063","authenticated-orcid":false,"given":"Joseph D.","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6932-8344","authenticated-orcid":false,"given":"Kenneth L.","family":"Kronstadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-6264","authenticated-orcid":false,"given":"Joseph M.","family":"Huryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-0671","authenticated-orcid":false,"given":"Cherry L.","family":"Estilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.oor.2024.100488_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American association of oral and maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oor.2024.100488_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2022.866871","article-title":"Oral complications in cancer patients-medication-related osteonecrosis of the jaw (MRONJ)","volume":"3","author":"Migliorati","year":"2022","journal-title":"Front Oral Health"},{"key":"10.1016\/j.oor.2024.100488_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/bonekey.2013.1","article-title":"Mechanisms of action of bisphosphonates in oncology: a scientific concept evolving from antiresorptive to anticancer activities","volume":"2","author":"Cl\u00e9zardin","year":"2013","journal-title":"BoneKEy Rep"},{"issue":"12","key":"10.1016\/j.oor.2024.100488_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.oor.2024.100488_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5489\/cuaj.117","article-title":"Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: incorporating new agents into clinical practice","volume":"6","author":"So","year":"2012","journal-title":"Can Urol Assoc J"},{"issue":"10","key":"10.1016\/j.oor.2024.100488_bib6","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/jbmr.4391","article-title":"Individualized bone-protective management in long-term cancer survivors with bone metastases","volume":"36","author":"Rachner","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.oor.2024.100488_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jbo.2017.09.003","article-title":"The skeletal-related events of denosumab versus zoledronic acid in patients with bone metastases: a meta-analysis of randomized controlled trials","volume":"9","author":"Zhang","year":"2017","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.oor.2024.100488_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2021.822411","article-title":"A review into the effects of pamidronic acid and zoledronic acid on the oral mucosa in medication-related osteonecrosis of the jaw","volume":"2","author":"Bullock","year":"2022","journal-title":"Front Oral Health"},{"key":"10.1016\/j.oor.2024.100488_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/clr.12556","article-title":"Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials","volume":"27","author":"Boquete-Castro","year":"2016","journal-title":"Clin Oral Implants Res"},{"issue":"3","key":"10.1016\/j.oor.2024.100488_bib10","first-page":"e326","article-title":"Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: a systematic review and meta-analysis","volume":"25","author":"Limones","year":"2020","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"3","key":"10.1016\/j.oor.2024.100488_bib11","first-page":"2341","article-title":"Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis","volume":"30","author":"Ikesue","year":"2022","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.oor.2024.100488_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.sdentj.2022.01.003","article-title":"Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies","volume":"34","author":"AlRowis","year":"2022","journal-title":"Saudi Dent J"},{"issue":"1","key":"10.1016\/j.oor.2024.100488_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/odi.13746","article-title":"Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer","volume":"28","author":"Van Poznak","year":"2022","journal-title":"Oral Dis"},{"issue":"3","key":"10.1016\/j.oor.2024.100488_bib14","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s00784-021-04261-4","article-title":"Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab","volume":"26","author":"Wick","year":"2022","journal-title":"Clin Oral Invest"},{"issue":"5","key":"10.1016\/j.oor.2024.100488_bib15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.oor.2024.100488_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cre2.698","article-title":"Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients-A systematic review","volume":"9","author":"Schwech","year":"2023","journal-title":"Clin Exp Dent Res"},{"issue":"4","key":"10.1016\/j.oor.2024.100488_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: a systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis"},{"issue":"7","key":"10.1016\/j.oor.2024.100488_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bjoms.2020.03.022","article-title":"Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ)","volume":"58","author":"Pichardo","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.oor.2024.100488_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jop.12963","article-title":"Association between periodontitis and medication-related osteonecrosis of the jaw: a systematic review and meta-analysis","volume":"49","author":"Lorenzo-Pouso","year":"2020","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"10.1016\/j.oor.2024.100488_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.oor.2024.100488_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.oor.2024.100488_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: a systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis"},{"issue":"11","key":"10.1016\/j.oor.2024.100488_bib23","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.joms.2018.05.025","article-title":"Nonsurgical management of medication-related osteonecrosis of the jaws using local wound care","volume":"76","author":"Hadaya","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"issue":"5 Suppl","key":"10.1016\/j.oor.2024.100488_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.oor.2024.100488_bib25","first-page":"679","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Henry","year":"2014","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.oor.2024.100488_bib26","first-page":"925","article-title":"Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review","volume":"29","author":"Ng","year":"2021","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.oor.2024.100488_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/2278-330X.119895","article-title":"Denosumab: a comprehensive review","volume":"2","author":"Narayanan","year":"2013","journal-title":"South Asian J Cancer"},{"issue":"2","key":"10.1016\/j.oor.2024.100488_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.oor.2024.100488_bib29","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","article-title":"Oral health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oor.2024.100488_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116722","article-title":"Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - a retrospective study of 240 patients","volume":"170","author":"Coropciuc","year":"2023","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.oor.2024.100488_bib31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jcpe.12455","article-title":"Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis","volume":"42","author":"Gaudin","year":"2015","journal-title":"J Clin Periodontol"},{"issue":"6","key":"10.1016\/j.oor.2024.100488_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"10.1016\/j.oor.2024.100488_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.oooo.2016.06.019","article-title":"Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series","volume":"122","author":"Owosho","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"10.1016\/j.oor.2024.100488_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.oooo.2019.08.004","article-title":"Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw","volume":"128","author":"Heifetz-Li","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Oral Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772906024003340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772906024003340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:52:53Z","timestamp":1763682773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772906024003340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"alternative-id":["S2772906024003340"],"URL":"https:\/\/doi.org\/10.1016\/j.oor.2024.100488","relation":{},"ISSN":["2772-9060"],"issn-type":[{"type":"print","value":"2772-9060"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of outcome in cancer patients with medication-related osteonecrosis of the jaw: A 19-year retrospective study","name":"articletitle","label":"Article Title"},{"value":"Oral Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oor.2024.100488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100488"}}